Sulfiredoxin as a Potential Therapeutic Target for Advanced and Metastatic Prostate Cancer

The incidence of prostate cancer (PCa) is increasing, and it is currently the second most frequent cause of death by cancer in men. Despite advancements in cancer therapies, new therapeutic approaches are still needed for treatment-refractory advanced metastatic PCa. Cross-species analysis presents...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oxid Med Cell Longev
Autors principals: Barquilha, Caroline N., Santos, Nilton J., Monção, Caio C. D., Barbosa, Isabela C., Lima, Flávio O., Justulin, Luis A., Pértega-Gomes, Nelma, Felisbino, Sérgio L.
Format: Artigo
Idioma:Inglês
Publicat: Hindawi 2020
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7201699/
https://ncbi.nlm.nih.gov/pubmed/32411320
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/2148562
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars